Cyproterone

TargetMol
Product Code: TAR-T21016
Supplier: TargetMol
CodeSizePrice
TAR-T21016-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21016-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T21016-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Cyproterone, an anti-androgen, is used in combination with estrogen for the therapy of hirsutism and severe acne in females and as a palliative in prostatic carcinoma.
CAS:
2098-66-0
Formula:
C22H27ClO3
Molecular Weight:
374.91
Purity:
0.98
SMILES:
CC(=O)[C@@]1(O)CC[C@@H]2[C@H]3C=C(Cl)C4=CC(=O)[C@H]5C[C@@H]5[C@@]4(C)[C@H]3CC[C@@]12C

References

1. Gruber DM, Sator MO, Joura EA, Kokoschka EM, Heinze G, Huber JC. Topical cyproterone acetate treatment in women with acne: a placebo-controlled trial. Arch Dermatol. 1998 Apr;134(4):459-63. PubMed PMID: 9554298. 2. Barradell LB, Faulds D. Cyproterone. A review of its pharmacology and therapeutic efficacy in prostate cancer. Drugs Aging. 1994 Jul;5(1):59-80. Review. PubMed PMID: 7919640. 3. Neumann F. The antiandrogen cyproterone acetate: discovery, chemistry, basic pharmacology, clinical use and tool in basic research. Exp Clin Endocrinol. 1994;102(1):1-32. Review. PubMed PMID: 8005205. 4. Goldenberg SL, Bruchovsky N. Use of cyproterone acetate in prostate cancer. Urol Clin North Am. 1991 Feb;18(1):111-22. Review. PubMed PMID: 1825143.